ElevateBio is a technology-driven advanced therapy contract development and manufacturing organization (CDMO) powering the creation of life-transforming therapies. The company helps biopharmaceutical partners design, develop, and manufacture therapies from early discovery through commercialization. Combining proprietary gene editing tools and services, cGMP manufacturing capabilities, and industry-leading expertise, ElevateBio is enabling partners advance a breadth of therapeutic approaches and modalities including cell therapies, gene edited therapies, RNA therapies, mRNA vaccines, and more.
| Website | https://www.elevate.bio/ |
| Revenue | $105.7 million |
| Employees | 485 (302 on RocketReach) |
| Address | 200 Smith St, Waltham, Massachusetts 02451, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+106 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Biologics Manufacturing, Cell Therapy, Gene Editing, Advanced Therapies, Biotechnology, Pharmaceutical Manufacturing, Oncology, Drug Development, Bioprocessing, Rare Diseases, Rna Therapeutics, Protein Engineering, Life Sciences, Immunotherapy, Precision Medicine, Regenerative Medicine, Translational Research, Clinical Trials, Pharmaceutical Research |
| Competitors | AstraZeneca, Receptos, a wholly-owned subsidiary of Celgene, CRISPR Therapeutics, Amgen, bluebird bio, Novartis, Vertex Pharmaceuticals, Sangamo Therapeutics, Inc., Zymergen, Inc., Moderna Therapeutics +52 more (view full list) |
Looking for a particular ElevateBio employee's phone or email?
The ElevateBio annual revenue was $105.7 million in 2026.
Christopher Murphy is the CEO of ElevateBio.
302 people are employed at ElevateBio.
ElevateBio is based in Waltham, Massachusetts.